2 December 2024 in Neuro-Oncology Practice
Background: Meningiomas frequently recur after surgery. Existing guidelines for postoperative surveillance are based on customary practices or limited data. This may result in excessive or inadequate surveillance. Methods: We compared 8 studies involving 1519 resected meningiomas with postoperative follow-up ranging from 7 to 23 years. Meningiomas were stratified using the World Health Organization and Simpson grading systems, and progression-free survival data were compared. Recurrence patterns were validated using 2 additional studies involving 2463 meningiomas. Results: Incompletely resected meningiomas of all grades displayed recurrences throughout the observation period. The 5-year and 10-year cumulative incidence of recurrence for completely resected Grade 1 meningiomas was 10% and 20%, with no recurrences beyond 11 years. For completely resected Grade 2 meningiomas, the 5-year and 10-year cumulative incidence of recurrence was 24% and 50%, with ongoing recurrences throughout the observation period. Elevated recurrence rates for Grade 1/2 meningiomas persisted beyond 5 years. For completely resected Grade 3 meningiomas, the 5-year cumulative incidence of recurrence was 63%, and all recurred before 10 years. Conclusions: Postoperative magnetic resonance imaging (MRI) at 48 h to determine the extent of resection and at 4 months to detect rapid regrowth is recommended. For completely resected Grade 1 meningiomas, annual MRI followed by discontinuation of surveillance if there is no recurrence after 11 years is reasonable. For completely resected Grade 2 meningiomas, annual MRI indefinitely is recommended. For Grade 3 meningiomas, MRI every 3-4 months for 2 years, followed by every 6 months indefinitely, is recommended. Incompletely resected meningiomas should be followed indefinitely.
10 June 2024 in Neurosurgery
BACKGROUND AND IMPORTANCE: Trephination is a procedure in which a small hole is made in the skull. Rare cases of self-trephination by individuals seeking medical benefit have been reported. Excoriation disorder is a compulsive skin-picking condition in which an individual self-inflicts cutaneous lesions. Left untreated, severe excoriation disorder can pose significant health risks. CLINICAL PRESENTATION: Here, we describe 5 patients who presented with self-trephination due to a severe form of compulsive cranial excoriation at 2 neighboring academic medical centers over a 4-year period. We review the clinical presentation of self-trephination in cranial excoriation disorder and associated risk factors, surgical and nonsurgical interventions, complications of the disease, treatments, and mortality. Defining clinical characteristics include repetitive self-induced destruction of the scalp and skull with entry into the intracranial compartment, frequent psychiatric comorbidities, infection or injury of the brain with consequent neurological morbidity or mortality, and frequent treatment failures because of poor adherence. CONCLUSION: Self-trephination in cranial excoriation disorder is a severe neuropsychological disorder and neurosurgical emergency that exposes the brain and is often life-threatening. Appropriate therapy requires antibiotics, surgical debridement and repair of the wound, and concomitant effective psychiatric management of the underlying compulsion, including the use of antidepressants and behavioral therapy.
15 September 2025 in Journal of Neurosurgery: Case Lessons
BACKGROUND: Primary melanoma in the spine is a rare tumor characterized by lack of primary dermal or uveal lesions. The infrequency of this tumor significantly obfuscates both its diagnosis and treatment. OBSERVATIONS: The authors describe the case of a 74-year-old male who presented with back pain, lower extremity weakness, and numbness. MRI revealed a contrast-enhancing intradural, extramedullary lesion at T11–12 with a hypointense signal on T2-weighted imaging. The patient underwent resection of the lesion. The diagnosis of primary spinal melanoma was confirmed by histopathology, immunohistochemical studies, and lack of primary lesions on dermatological and ophthalmological examination. Next-generation sequencing also revealed a guanine-nucleotide binding protein ( GNAQ ) mutation. LESSONS: The authors present a potential mechanism of primary spinal melanoma tumorigenesis associated with GNAQ . GNAQ mutations lead to abnormal β-catenin activation in neural crest cells, resulting in differentiation into melanoblasts and migration to the spinal cord. Over time, GNAQ mutations can lead to aberrant proliferation of ectopic melanocytes due to downstream activation of the RAS / RAF signaling pathway. Understanding this pathomechanism and its role in primary CNS melanoma may provide a route for potential targeted therapy. https://thejns.org/doi/10.3171/CASE25183
26 October 2026 in Journal of Neurosurgery: Case Lessons
BACKGROUND: Pituitary adenomas (PAs) are common benign intracranial neoplasms. Transsphenoidal resection is the standard of care for symptomatic tumors, with surgical complications including CSF leakage, infection, hormonal disturbances, and postoperative hematomas leading to visual decline. Rapid postoperative cyst development leading to acute visual deterioration is a rare but potentially significant complication. OBSERVATIONS: A 63-year-old female with headaches and pulsatile tinnitus presented with a large PA compressing the optic apparatus. Transsphenoidal surgery (TSS) via an endoscopic endonasal approach was performed. On postoperative day 6, the patient experienced rapid onset of bitemporal hemianopsia, and imaging revealed a new suprasellar cystic lesion. The patient underwent emergency craniotomy for cyst resection, with pathological analysis demonstrating a nonneoplastic anterior pituitary gland. A systematic literature review of rapid cyst formation following TSS yielded only 1 article for inclusion. No cases of a postoperative cyst of normal pituitary gland origin were identified. LESSONS: Visual decline following TSS is typically due to a sellar/suprasellar hematoma, abscess, or CSF accumulation. Few reports attribute acute postoperative visual deterioration to the development of a secondary pituitary mass, typically due to PA recurrence or formation of a suprasellar cyst. Emergency cyst resection via a transcranial approach resulted in restoration of vision and preservation of pituitary function, supporting aggressive surgical management. https://thejns.org/doi/10.3171/CASE26459
16 February 2026 in Journal of Neurosurgery: Case Lessons
BACKGROUND: Isocitrate dehydrogenase ( IDH ) is a commonly mutated gene in gliomas. Although IDH -mutant WHO grade 4 astrocytomas tend to occur in younger patients and show an improved survival compared to IDH -wildtype, prognosis remains poor and treatment options are limited. Ivosidenib is a small-molecule inhibitor of IDH-1 that has shown promise for treating low-grade IDH -mutant glioma. However, little is known about its efficacy in IDH -mutant WHO grade 4 astrocytoma. OBSERVATIONS: The authors present the case of a 36-year-old male with a IDH -mutant WHO grade 4 astrocytoma. He was originally treated with resection, followed by radiation therapy and temozolomide. At the second recurrence, ivosidenib was started, after lomustine therapy had failed to control the disease. Radiological surveillance showed interval decrease in tumor size starting 2 months after initiation of ivosidenib. The patient remained neurologically intact, and no adverse effects were observed. LESSONS: Here the authors report the effects of the off-label use of ivosidenib. The INDIGO trial published evidence of efficacy in using an IDH inhibitor for low-grade gliomas. The role of these drugs in high-grade IDH -mutant gliomas is currently unknown. Further studies are needed to assess their impact on overall and progression-free survival. https://thejns.org/doi/10.3171/CASE25572
11 January 2022 in Clinical Case Reports
Bacterial translocation as a mechanism of distal catheter infection may play a larger role in ventriculoperitoneal shunt infections than previously recognized.